ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,683Medicare Part D Prescriptions Filled, Including Refills

Rank: 276 out of 780

$668K Total Retail Price of All Prescriptions

Rank: 187 out of 780

454 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

22% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

1% of this provider’s 7,693 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
AMLODIPINE BESYLATE 420 320 1 4
HYDROCODONE-ACETAMINOPHEN 388 192 S3 2 1
SIMVASTATIN 360 317 3 2
FUROSEMIDE 348 289 4 7
CRESTOR 263 203 5 32
ATORVASTATIN CALCIUM 237 211 6 12
MELOXICAM 229 189 7 16
PANTOPRAZOLE SODIUM 202 113 8 25
HYDROCHLOROTHIAZIDE 197 133 9 10
CARVEDILOL 189 108 10 14
TRIAMTERENE-HCTZ 189 151 10 37
AMLODIPINE BESYLATE-BENAZEPRIL 173 135 12 50
NIFEDIPINE ER 169 133 13 115
NEXIUM 169 95 13 22
SINGULAIR 152 79 15 73
PRAVASTATIN SODIUM 151 114 16 9
KLOR-CON M20 143 103 17 57
OMEPRAZOLE 133 79 18 3
LOSARTAN POTASSIUM 127 85 19 18
CLONIDINE HCL 125 75 20 28
GLIMEPIRIDE 123 119 21 30
LISINOPRIL 116 95 22 6
PLAVIX 114 103 23 45
DIOVAN HCT 107 78 24 75
MONTELUKAST SODIUM 106 54 25 120
FOSINOPRIL SODIUM 106 72 25 112
POTASSIUM CHLORIDE 104 94 27 11
TRAZODONE HCL 103 48 28 35
ALLOPURINOL 101 75 29 29
SPIRONOLACTONE 94 62 30 53
METFORMIN HCL 91 62 31 8
METOPROLOL TARTRATE 90 45 32 19
CLOPIDOGREL 87 86 33 34
TRAMADOL HCL 85 63 34 15
GABAPENTIN 81 43 35 13
CYMBALTA 76 61 36 51
GLYBURIDE-METFORMIN HCL 75 36 R 37 108
IBUPROFEN 75 43 37 93
LOSARTAN-HYDROCHLOROTHIAZIDE 75 63 37 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 45 40 26
ATENOLOL 73 44 40 21
INSULIN SYRINGE 72 47 42 80
LEVOTHYROXINE SODIUM 72 59 42 5
TAMSULOSIN HCL 70 64 44 36
SPIRIVA 70 67 44 72
AMOX TR-POTASSIUM CLAVULANATE 69 33 46 135
VESICARE 69 60 46 186
NIFEDICAL XL 66 43 48 209
HYDRALAZINE HCL 62 47 49 54
DOXYCYCLINE HYCLATE 61 36 50 103
WARFARIN SODIUM 60 39 51 24
ESCITALOPRAM OXALATE 60 46 51 61
NAMENDA 59 56 53 46
RISPERIDONE 57 57 54 98
BYSTOLIC 56 40 55 118
NOVOLOG MIX 70-30 55 54 56 328
FELODIPINE ER 54 53 57 126
DONEPEZIL HCL 50 50 58 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 18, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.